Package 69315-318-20

{"route": ["ORAL"], "spl_id": "0267a67e-d492-480b-a688-e2cec27142a6", "openfda": {"nui": ["N0000008486"], "upc": ["0369315318461"], "unii": ["563KS2PQY5"], "rxcui": ["993856"], "spl_set_id": ["45786c84-51ef-4440-bc88-2501951e4c41"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Leading Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "200 mL in 1 BOTTLE, PLASTIC (69315-318-20)", "package_ndc": "69315-318-20", "marketing_start_date": "20230725"}, {"sample": false, "description": "465 mL in 1 BOTTLE, PLASTIC (69315-318-46)", "package_ndc": "69315-318-46", "marketing_start_date": "20230725"}], "brand_name": "Lacosamide", "product_id": "69315-318_0267a67e-d492-480b-a688-e2cec27142a6", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "69315-318", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "Leading Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "ANDA216461", "marketing_category": "ANDA", "marketing_start_date": "20230206", "listing_expiration_date": "20261231"}